Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

BACKGROUND: Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust...

詳細記述

保存先:
書誌詳細
出版年:Malar J
主要な著者: Belew, Sileshi, Suleman, Sultan, Duguma, Markos, Teshome, Henok, Wynendaele, Evelien, Duchateau, Luc, De Spiegeleer, Bart
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140584/
https://ncbi.nlm.nih.gov/pubmed/32264882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03209-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料